Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04041-z
Abstract: Purpose Ivermectin is an antiparasitic drug that exhibits antitumor effects in preclinical studies, and as such is currently being repositioned for cancer treatment. However, divergences exist regarding its employed doses in preclinical works. Therefore, the… read more here.
Keywords: antitumor effects; drug; cancer; repositioned cancer ... See more keywords